GWPH
$136.44
Gw Pharma ADR
$.72
.53%
GWPH
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.77)
Revenue:  $143.57 Mil
Tuesday
Feb 2
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GWPH reports earnings?
Beat
Meet
Miss

Where is GWPH's stock price going from here?
Up
Flat
Down
Stock chart of GWPH
Analysts
Summary of analysts' recommendations for GWPH
Score
Grade
Pivots
Resistance
$142.87
$140.27
$138.35

$135.75

Support
$133.83
$131.23
$129.31
Tweet
Growth
Description
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.